CASI Pharmaceuticals
CASI
#8881
Rank
NZ$0.14 B
Marketcap
$9.53
Share price
0.47%
Change (1 day)
27.14%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -NZ$44.27 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are NZ$23.1 Million. In 2023 the company made an earning of -NZ$45.07 Million, an increase over its 2022 earnings that were of -NZ$63.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$44.27 Million-1.77%
2023 -NZ$45.07 Million-29.55%
2022 -NZ$63.97 Million4.43%
2021 -NZ$61.26 Million-24.56%
2020 -NZ$81.2 Million4.74%
2019 -NZ$77.52 Million65.13%
2018 -NZ$46.95 Million155.07%
2017 -NZ$18.41 Million13.93%
2016 -NZ$16.16 Million31.18%
2015 -NZ$12.32 Million-72.5%
2014 -NZ$44.78 Million356.62%
2013 -NZ$9.81 Million-60.55%
2012 -NZ$24.86 Million218.41%
2011 -NZ$7.81 Million0.74%
2010 -NZ$7.75 Million-32.54%
2009 -NZ$11.49 Million-66.98%
2008 -NZ$34.79 Million-14.22%
2007 -NZ$40.56 Million7.04%
2006 -NZ$37.89 Million27.95%
2005 -NZ$29.62 Million4.51%
2004 -NZ$28.34 Million-15.84%
2003 -NZ$33.67 Million-55.29%
2002 -NZ$75.31 Million-34.05%
2001 -NZ$0.12 Billion31.73%
2000 -NZ$86.68 Million31.56%
1999 -NZ$65.89 Million145.56%
1998 -NZ$26.83 Million76.4%
1997 -NZ$15.21 Million36.92%
1996 -NZ$11.11 Million